MYDX, CannaDx, ECO Smart Pen, Big Pharma, Oh My!
Post# of 1481
(Total Views: 798)
Posted On: 06/22/2017 7:28:15 PM
MYDX, CannaDx, ECO Smart Pen, Big Pharma, Oh My!
It doesn't take but a couple Google searches to learn the true history of cannabis as it relates to the world. It takes just a small amount of reading to see how it was brought from one of the most widely used products in the world down to virtually unavailable. It will also literally sicken you as to the reasoning but that is a discussion for another forum.
MYDX CannaDx focuses on marijuana, analyzing the plants chemical composition to determine medical and therapeutic benefits. The analyzer also allows the user to create a personal profile for the strains purchased. This makes it possible to match a chemical profile to the user based on whatever result is desired allowing them to duplicate this over and over. More importantly, by transferring this information into a database it allows others to test, confirm or modify their individual reaction thus ever expanding the collective data.
What does all this have to do with big pharma you may ask. Everything! First off nothing has really changed in the world of business since a relatively small group forced marijuana into the realm of criminal substances. And those same forces are about to bring it right back, for a profit.
While Mr. Yazbeck is pushing MYDX as a source of verification and transparency to help cannabis users, which is absolutely accurate, the device has other uses. After years in the medical and electronics industries he knows full well what the corporate world is looking at in MYDX.
Medical electronics corporations know that with any medicine one of the hardest things to get right is dosage. No one person is the same so instruments that aid the doctor patient relationship in monitoring dosage verse reaction are invaluable. The ability to record this individually and be
monitored remotely by the physician is even more valuable for personalized care. Both the CannaDx and ECO Smart Pen will make this a reality for physicians prescribing medical marijuana. The applications in just this market is extensive. Physicians would be able to create a database based on the clinics results to better aid in treating the ailments they specialize in.
Insurance corporations pay for the prescriptions any patient under their coverage uses. Better control and tracking of this is money in the bank for them, no different than over prescribing any other drug. ECO Smart Pen could easily be designed for low cost pre-filled applications just like diabetes pens.
Big Pharma will want everything MYDX has to offer but the data will be indispensable. They had no doubt this momentum would shift and all the lobbying against cannabis was not to stop it but delay it. Why? Big companies move slow and if they have to move fast it costs money, lots of it. Moreover, the slower the transition the easier for them to lobby for controls in their favor. Mr. Yazbeck knows this for a fact from experience in that industry. He also knows the interest in the data will be far more valuable to them. While they will no doubt start swallowing up grow facilities, the data will be so they can synthesize the chemicals in marijuana and have something to match it to. The plant is expensive to grow which eats all the profit out of the medical aspect. If they can duplicate it in synthetic form, patent and license it now they have the control back with a huge profit margin.
I believe we will see the elite growers become more like micro brewers and small vineyards, reduced to recreational markets selling only top shelf. I can also see once the data is more known our government controlling even what strains with associated chemical compositions are available for recreation in an effort to control THC levels as well as medical value. Much like volume percentage on alcohol with the medical value being lobbied for by big pharma.
For MYDX there is exponential profit potential at every turn. A closer look at MYDX and you will see they have been crazy like a fox from the onset. Hasn't been an easy road by any means but what business venture is for the small businessman?
http://www.insysrx.com/products/in-development
https://www.theguardian.com/us-news/2017/apr/...ys-arizona
http://www.huffingtonpost.com/alice-oleary-ra...25956.html
http://www.alternet.org/story/90469/big_pharm..._to_market
https://motherboard.vice.com/en_us/article/wj...mpounds-nd
http://www.advancedholistichealth.org/history.html
https://www.livescience.com/48337-marijuana-h...world.html
http://druglibrary.org/schaffer/hemp/history/....htm#intro
It doesn't take but a couple Google searches to learn the true history of cannabis as it relates to the world. It takes just a small amount of reading to see how it was brought from one of the most widely used products in the world down to virtually unavailable. It will also literally sicken you as to the reasoning but that is a discussion for another forum.
MYDX CannaDx focuses on marijuana, analyzing the plants chemical composition to determine medical and therapeutic benefits. The analyzer also allows the user to create a personal profile for the strains purchased. This makes it possible to match a chemical profile to the user based on whatever result is desired allowing them to duplicate this over and over. More importantly, by transferring this information into a database it allows others to test, confirm or modify their individual reaction thus ever expanding the collective data.
What does all this have to do with big pharma you may ask. Everything! First off nothing has really changed in the world of business since a relatively small group forced marijuana into the realm of criminal substances. And those same forces are about to bring it right back, for a profit.
While Mr. Yazbeck is pushing MYDX as a source of verification and transparency to help cannabis users, which is absolutely accurate, the device has other uses. After years in the medical and electronics industries he knows full well what the corporate world is looking at in MYDX.
Medical electronics corporations know that with any medicine one of the hardest things to get right is dosage. No one person is the same so instruments that aid the doctor patient relationship in monitoring dosage verse reaction are invaluable. The ability to record this individually and be
monitored remotely by the physician is even more valuable for personalized care. Both the CannaDx and ECO Smart Pen will make this a reality for physicians prescribing medical marijuana. The applications in just this market is extensive. Physicians would be able to create a database based on the clinics results to better aid in treating the ailments they specialize in.
Insurance corporations pay for the prescriptions any patient under their coverage uses. Better control and tracking of this is money in the bank for them, no different than over prescribing any other drug. ECO Smart Pen could easily be designed for low cost pre-filled applications just like diabetes pens.
Big Pharma will want everything MYDX has to offer but the data will be indispensable. They had no doubt this momentum would shift and all the lobbying against cannabis was not to stop it but delay it. Why? Big companies move slow and if they have to move fast it costs money, lots of it. Moreover, the slower the transition the easier for them to lobby for controls in their favor. Mr. Yazbeck knows this for a fact from experience in that industry. He also knows the interest in the data will be far more valuable to them. While they will no doubt start swallowing up grow facilities, the data will be so they can synthesize the chemicals in marijuana and have something to match it to. The plant is expensive to grow which eats all the profit out of the medical aspect. If they can duplicate it in synthetic form, patent and license it now they have the control back with a huge profit margin.
I believe we will see the elite growers become more like micro brewers and small vineyards, reduced to recreational markets selling only top shelf. I can also see once the data is more known our government controlling even what strains with associated chemical compositions are available for recreation in an effort to control THC levels as well as medical value. Much like volume percentage on alcohol with the medical value being lobbied for by big pharma.
For MYDX there is exponential profit potential at every turn. A closer look at MYDX and you will see they have been crazy like a fox from the onset. Hasn't been an easy road by any means but what business venture is for the small businessman?
http://www.insysrx.com/products/in-development
https://www.theguardian.com/us-news/2017/apr/...ys-arizona
http://www.huffingtonpost.com/alice-oleary-ra...25956.html
http://www.alternet.org/story/90469/big_pharm..._to_market
https://motherboard.vice.com/en_us/article/wj...mpounds-nd
http://www.advancedholistichealth.org/history.html
https://www.livescience.com/48337-marijuana-h...world.html
http://druglibrary.org/schaffer/hemp/history/....htm#intro
(0)
(0)